Emmis Acquisition (EMIS) vs Minerva Neurosciences (NERV)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Emmis Acquisition is the larger company by market cap ($162.0 million vs $156.1 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EMIS | NERV |
|---|---|---|
| Share price | $10.27 | $3.27 |
| Market cap | $162.02M | $156.13M |
| 1-day change | 0.00% | -4.66% |
| YTD return | +3.22% | -18.66% |
| 1-year return | — | +50.00% |
| 5-year return | — | -69.72% |
| EPS (TTM) | — | $-34.49 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $10.27 | $12.46 |
| 52-week low | $9.90 | $2.24 |
| Distance from 52-week high | 0.00% | -73.76% |
| Average volume | 13.89K | 185.68K |
| Shares outstanding | 11.94M | 47.75M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
EMIS vs NERV FAQ
Which is bigger, Emmis Acquisition or Minerva Neurosciences?
Emmis Acquisition (EMIS) is larger, with a market capitalization of $162.02M compared with $156.13M for Minerva Neurosciences (NERV).
Are Emmis Acquisition and Minerva Neurosciences in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.